e-ISSN: Pending
Negative / Null Result Report

Effect of Low-Dose Rivaroxaban Plus Aspirin on Carotid Plaque Inflammation (SPIRIT): A Randomized 18F-FDG PET/CT Trial

Kim TO; Han S; Lee JB; Suh CH; Kang S; Moon DH; Lee CW; Gwon JG · 2025 · Preprint

WASTE classifies this as Negative / Null Result Report · AI classification, approximate

The study found no significant effect — useful as a negative control or null benchmark for your own design.

Abstract (excerpt)

Background: Aspirin plus rivaroxaban reduces cardiovascular events in patients with stable atherosclerosis; however, whether Factor Xa inhibition attenuates arterial wall inflammation in humans remains unclear. Methods: We conducted a…

Excerpt shown for reference under fair use — read the full paper at the publisher.

Read full paper at publisher

Hosted by the publisher — may require access.

About to run something similar?

Run an AI Precheck on your own design to catch failure modes like this one before you spend the time. Your first desk check is free.

WASTE indexes this work — it does not host or republish it. Failure-type classification is automated and approximate.

Metadata source: Europe PMC · DOI 10.1101/2025.11.18.25340536